Management peculiarities of patients with chronic tonsillitis in comorbid conditions

Introduction. Chronic tonsillitis (CT) remains an urgent challenge in outpatient practice of not only otorhinolaryngologists, but also multi-discipline specialists – primary care physicians and general practitioners.

Aim. To study the effectiveness of Tonsilgon® N at the outpatient care stage in CT patients with and without comorbidities. Materials and methods. 62 patients (30 to 56 years of age, average age 43.8 ± 13.2 years) with compensated CT were treated. The patients were divided into two groups: Group 1 (n = 30) included patients with compensated CT, Group 2 (n = 32) – patients with compensated CT and comorbidities: diabetes mellitus was detected in 40.6%, autoimmune thyroiditis in 43.7%, psoriasis in 15.7% of examined patients.

Results and discussion. Evaluation of treatment outcomes using a 10-point visual analogue scale showed a significant (p < 0.05) health improvement in patients of both groups who received Tonsilgon® N. The examination showed a 1.8-fold decrease in the severity of the local symptom of CT – hyperemia and a roll-like thickening of the edges of the pillars of the fauces in patients of both groups by the 7th day of treatment. The trends of changes were characterized by uniformity, amounting to 0.09 ± 0.02 scores in Group 1 and 0.1 ± 0.02 scores in Group 2 (p < 0.05) by the 14th day of treatment. In CT patients without comorbidities, exacerbations that developed within 3 months were only observed in 6.6% of patients, and occurred in a mild form, which made it possible to abandon the use of antibacterials for systemic use; in Group 2 with comorbidities, they were more common and developed in 12.5% of patients.

Conclusion. The high rate of successful treatment outcomes confirms the safety of the drug as an effective agent to relieve the severity of CT symptoms.

1. Popovych V, Koshel I, Malofiichuk A, Pyletska L, Semeniuk A, Filippova O, Orlovska R. A randomized, open-label, multicenter, comparative study of therapeutic efficacy, safety and tolerability of BNO 1030 extract, containing marshmallow root, chamomile flowers, horsetail herb, walnut leaves, yarrow herb, oak bark, dandelion herb in the treatment of acute non-bacterial tonsillitis in children aged 6 to 18 years. Am J Otolaryngol. 2019;40(2):265–273. https://doi.org/10.1016/j.amjoto.2018.10.012.

2. Garashchenko T, Volodarskaya V. Bacterial lysates mixture for the topical administration in prophylaxis and treatment of chronic tonsillitis in children. Current Pediatrics. 2009;8(6):109–112. (In Russ.) Available at: https://vsp.spr-journal.ru/jour/article/view/1203/0.

3. Palchun VT, Gurov AV, Aksenova AV, Guseva OA. The modern view of toxicoallergic manifestations of chronic tonsillar pathology, its etiological and pathological role in the evolvement and development of general diseases. Vestnik Oto­Rino­Laringologii. 2012;77(2):5–12. (In Russ.) Available at: https://www.mediasphera.ru/issues/vestnik-otorinolaringologii/2012/2/030042-4668201221.

4. Karpishchenko SA, Lavrenova GV, Baranskaya SV. Tonsillitis and tonsillogenic conditions. Vestnik Oto­Rino­Laringologii. 2016;81(4):69–71. (In Russ.) https://doi.org/10.17116/otorino201681469-71.

5. Laiko AA, Gavrilenko YuV, Volgina IE. Functional state of the palatine tonsils in children with type 1 diabetes mellitus. ScienceRise. 2016;1(3):71–76. (In Russ.) https://doi.org/10.15587/2313-8416.2016.59330.

6. Biryukova EV, Gurov AV, Yushkina MA. Diabetes mellitus and pyoinflammatory diseases of ENT organs. Diabetes Mellitus. 2012;15(2):54–59. (In Russ.) https://doi.org/10.14341/2072-0351-5519.

7. Ikoma R, Arai Y, Yamamoto S, Tsukuda M. A case of thyroid crisis in acute tonsillitis treatment. Nihon Jibiinkoka Gakkai Kaiho. 2010;113(7):602–606. (In Japanese) https://doi.org/10.3950/jibiinkoka.113.602.

8. Rendon A, Schäkel K. Psoriasis Pathogenesis and Treatment. Int J Mol Sci. 2019;20(6):1475. https://doi.org/10.3390/ijms20061475.

9. Sigurdardottir SL, Thorleifsdottir RH, Valdimarsson H, Johnston A. The role of the palatine tonsils in the pathogenesis and treatment of psoriasis. Br J Dermatol. 2013;168(2):237–242. https://doi.org/10.1111/j.1365-2133.2012.11215.x.

10. Chevretton EB, Davis JP. Tonsillitis: its causes, management and possible complications. Int J Clin Pract. 1997;51(8):485–486. Available at: https://pubmed.ncbi.nlm.nih.gov/9536597/.

11. Артюшкин СА, Еремина НВ, Рязанцев СВ, Карнеева ОВ, Крюков АИ, Кунельская НЛ. Хронический тонзиллит: клинические рекомендации. М.; 2021. 47 с. Режим доступа: https://cr.minzdrav.gov.ru/recomend/683_1.

12. Kryukov AI, Kunelskaya NL, Tsarapkin GYu, Izotova GN, Tovmasyan AS, Luchsheva YuV. The study of the efficacy and safety of Tonsilgon® N in the treatment of chronic pharyngitis. Meditsinskiy Sovet. 2016;(17):42–44. (In Russ.) https://doi.org/10.21518/2079-701X-2016-17-42-44.

13. Preobrazhenskaya YuS, Drozdova MV, Ryazantsev SV. Etiological aspects of chronic pathology of the lymphepithelial pharyngeal ring in children at the present stage. Meditsinskiy Sovet. 2021;(18):100–105. (In Russ.) https://doi.org/10.21518/2079-701X-2021-18-100-105.

14. Drynov GI, Ivanyushina OK, Dyakova FN. Tonsilgon® N in therapy of chronic tonsillitis in children. Effective Pharmacotherapy. 2014;(3):4–6. (In Russ.) Available at: https://umedp.ru/upload/iblock/3b1/3b1766f5eb91a9eefe9cec94c1aa9f3c.pdf.

15. Gurov AV, Yushkina MA. Opportunities of Tonsilgon® N use in complex treatment of chronic tonsillitis. Consilium Medicum. 2018;20(11):20–24. (In Russ.) Available at: https://consilium.orscience.ru/2075-1753/article/view/95100.

16. Drozdova MV, Ryazantsev SV. The experience of administration of the preparation tonsilgon n in treatment of chronic tonsillitis in sickly children. Rossiiskaya Otorinolaringologiya. 2016;(5):120–125. (In Russ.) https://doi.org/ 10.18692/1810-4800-2016-5-120-125.

17. Klimova II, Bazhenov DV. The effectiveness of a herbal preparation Tonsilgon N for the treatment of the children presenting with chronic adenoiditis. Vestnik Oto­Rino­Laringologii. 2014;(2):75–78. (In Russ.) Available at: https://www.mediasphera.ru/issues/vestnik-otorinolaringologii/2014/2/030042-46682014217.

18. Солдатов ИБ (ред.). Руководство по оториноларингологии. 2-е изд. М.: Медицина; 1997. 608 с.

19. Чечко АН. Программа для диагностики гнойно­воспалительных заболеваний глотки. Свидетельство о государственной регистрации программы для ЭВМ RU 2021666205, 11.10.2021. Режим доступа: https://www.fips.ru/iiss/document.xhtml?faces-redirect=true&id=a18b0f73b024b1d04f82c021f3d7bb63.